About
John O’Donnell is Vice President, Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb. He leads a diverse global team of sixty scientists dedicated to defining, developing and delivering evidence of value to ensure patients, payers and providers have the best possible information about, and optimal access to, BMS’ innovative medicines. Over his career he has developed, launched and commercialized over 20 medicines in respiratory, cardiovascular, HCV, genito-urinary, transplant, diabetes, and oncology including the industry-leading BMS medicines in immuno-oncology, Yervoy and OPDIVO, and the blockbusters Advair, Crestor, Symbicort, Iressa, Daklinza and Eliquis.
Dr. O’Donnell is an international leader in health technology assessment with work experience in the US, Europe and Asia, and as a regional Head based in the US and UK. He is Chair of the Academy Health's Corporate Council, former Chair of the Institutional Council of the International Society of Pharmacoeconomics and Outcomes Research and was the lead author and editor of the Value in Health Special Issues, Health Technology Assessment in Evidence-Based Health Care Reimbursement Decisions Around the World and Personalized Medicine and the Role of Health Economics and Outcomes Research.
He holds a Masters in policy analysis and a Doctorate in health policy and administration from the University of North Carolina at Chapel Hill. He has twenty six years of experience in health services and outcomes research in industry, in academia and in US State and Federal governments, with nearly twenty years of experience in the pharmaceutical industry. While in government and academia, he advanced health policy research in rehabilitation services, veterans’ health and the aged through his work with the US Department of Veterans Affairs and Duke University’s Center for the Study of Aging and Human Development. He also analyzed optimal social service and primary care delivery models for foster care and geriatric team care.
He is Adjunct Professor at the University of North Carolina at Chapel Hill, has published in the areas of health economic evaluation, health policy, health services research, geriatrics and rehabilitation and is a reviewer for a number of leading journals.
Education
- BA, Social Sciences, Saint Bonaventure University
- MPP, Public Policy, State University of New York at Albany, 1991
- PhD, Health Policy and Administration, University of North Carolina at Chapel Hill, 1999
